Middle East and Africa Biologics Market Report

1. Middle East and Africa Biologics Market Research Report
1. 1.1 Study Objectives
2. 1.2 Middle East and Africa Biologics Market - Overview
3. 1.3 Reason to Read This Report
4. 1.4 Methodology and Forecast Analysis
2. Middle East and Africa Biologics Market Research Report - Preface
1. 2.1 Middle East and Africa Biologics Market Research Report – Detailed Scope and Definitions
1. 2.1.1 By Product Type
2. 2.1.2 By Therapeutic Area
3. 2.1.3 By Manufacturing Process
4. 2.1.4 By Region
3. Middle East and Africa Biologics Market Dynamics
1. 3.1. Drivers - Macro-Economic Based, Supply Side, and Demand Side Drivers
2. 3.2. Restraints – By Product Type, By Therapeutic Area, By Manufacturing Process, By Country
3. 3.3. Opportunities – By Product Type, By Therapeutic Area, By Manufacturing Process, By Country
4. 3.4. Trends – By Product Type, By Therapeutic Area, By Manufacturing Process, By Country
5. 3.5. PEST Analysis
6. 3.6. Porters Five Rule Analysis
7. 3.7. Company’s Share Analysis (CSA) by Region or By Country
8. 3.8. Middle East and Africa Biologics Market Research Report – DROTs Impact Analysis
4. Middle East and Africa Biologics Market Research Report, Historic Data 2019 - 2023 and Forecast Analysis Data 2024 - 2031
1. 4.1. Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
2. 4.2. Annual Market Trend Assessment – Year-on-Year (YoY) Growth Analysis (%)
3. 4.3. Incremental Market Value/Volume Opportunity between 2019 - 2023 and 2024 - 2031
4. 4.4. Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
5. Middle East and Africa Biologics Market, By Product Type, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
1. 5.1 Monoclonal Antibodies
1. 5.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
2. 5.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
3. 5.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
4. 5.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
2. 5.2 Vaccines
1. 5.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
2. 5.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
3. 5.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
4. 5.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
3. 5.3 Recombinant Proteins
1. 5.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
2. 5.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
3. 5.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
4. 5.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
4. 5.4 Cell Therapy
1. 5.4.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
2. 5.4.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
3. 5.4.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
4. 5.4.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
5. 5.5 Gene Therapy
1. 5.5.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
2. 5.5.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
3. 5.5.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
4. 5.5.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
6. Middle East and Africa Biologics Market, By Therapeutic Area, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
1. 6.1 Oncology
1. 6.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
2. 6.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
3. 6.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
4. 6.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
2. 6.2 Autoimmune Diseases
1. 6.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
2. 6.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
3. 6.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
4. 6.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
3. 6.3 Infectious Diseases
1. 6.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
2. 6.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
3. 6.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
4. 6.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
4. 6.4 Cardiovascular Diseases
1. 6.4.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
2. 6.4.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
3. 6.4.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
4. 6.4.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
5. 6.5 Neurology
1. 6.5.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
2. 6.5.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
3. 6.5.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
4. 6.5.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
6. 6.6 Others
1. 6.6.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
2. 6.6.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
3. 6.6.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
4. 6.6.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
7. Middle East and Africa Biologics Market, By Manufacturing Process, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
1. 7.1 Outsourced
1. 7.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
2. 7.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
3. 7.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
4. 7.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
2. 7.2 In-House
1. 7.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
2. 7.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
3. 7.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
4. 7.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
8. Middle East and Africa Biologics Market Forecast, By Region, 2019 - 2023 and 2024 - 2031 (Market Value, In USD Mn)
1. 8.1 Middle East and Africa
   1. 8.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
   2. 8.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
   3. 8.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
   4. 8.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
8.2 Middle East and Africa Biologics Market - Opportunity Analysis Index, By Product Type, By Therapeutic Area, By Manufacturing Process, and Region, 2024 - 2031
9. Middle East and Africa Middle East and Africa Biologics Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
9.1 By Product Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
1. 9.1.1 Monoclonal Antibodies
2. 9.1.2 Vaccines
3. 9.1.3 Recombinant Proteins
4. 9.1.4 Cell Therapy
5. 9.1.5 Gene Therapy
9.2 By Therapeutic Area Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
1. 9.2.1 Oncology
2. 9.2.2 Autoimmune Diseases
3. 9.2.3 Infectious Diseases
4. 9.2.4 Cardiovascular Diseases
5. 9.2.5 Neurology
6. 9.2.6 Others
9.3 By Manufacturing Process Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
1. 9.3.1 Outsourced
2. 9.3.2 In-House
9.4 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
1. 9.4.1 Saudi Arabia
2. 9.4.2 UAE
3. 9.4.3 South Africa
4. 9.4.4 Egypt
5. 9.4.5 Israel
6. 9.4.6 Rest of Middle East and Africa
9.5 Middle East and Africa Middle East and Africa Biologics Market – Opportunity Analysis Index, By Product Type, By Therapeutic Area, By Manufacturing Process, and Country, 2024 - 2031
9.6 Regional Trends Analysis
9.7 Middle East and Africa Middle East and Africa Biologics Market Research Report - Company Profiles
1. 9.7.1 Company 1 (Saudi Arabia)
2. 9.7.2 Company 2 (UAE)
3. 9.7.3 Company 3 (UAE)
10. Competition Landscape
10.1 Strategic Dashboard of Top Market Players
10.2 Company Profiles (Introduction, Financial Assessments, Portfolio of Offerings, Milestones and Achievements, Strategic Initiative, and SWOT Analysis)

1. 10.2.1 Roche Holding AG
2. 10.2.2 Pfizer Inc.
3. 10.2.3 Johnson & Johnson
4. 10.2.4 Amgen Inc.
5. 10.2.5 AbbVie Inc.
11. Data Collection Method and Research Approach
12. Principal Presumptions and Acronyms